(IHG) InterContinental Hotels - Overview
Exchange: NYSE •
Country: United Kingdom •
Currency: USD •
Type: Common Stock •
ISIN: US45857P8068
Stock:
Total Rating 52
Risk 76
Buy Signal 0.03
| Risk 5d forecast | |
|---|---|
| Volatility | 29.9% |
| Relative Tail Risk | -5.08% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.28 |
| Alpha | -8.36 |
| Character TTM | |
|---|---|
| Beta | 0.870 |
| Beta Downside | 0.853 |
| Drawdowns 3y | |
|---|---|
| Max DD | 28.13% |
| CAGR/Max DD | 0.98 |
EPS (Earnings per Share)
Revenue
Description: IHG InterContinental Hotels
InterContinental Hotels Group PLC owns, manages, franchises, and leases hotels in the United Kingdom, the United States, and internationally. It operates hotels under the Six Senses, Regent, InterContinental Hotels & Resorts, Vignette Collection, Kimpton Hotel, Hotel Indigo, voco, Ruby, HUALUXE, Crowne Plaza, Iberostar Beachfront Resorts, EVEN Hotels, Holiday Inn Express, Holiday Inn, Garner, avid hotels, Atwell Suites, Staybridge Suites, IHG, Holiday Inn Club Vacations, and Candlewood Suites brand names. The company also provides IHG Rewards loyalty program. InterContinental Hotels Group PLC was formerly known as Six Continents PLC and changed its name to InterContinental Hotels Group PLC in June 2003. The company was founded in 1777 and is headquartered in Windsor, United Kingdom.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 1.39b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.29 > 0.02 and ΔFCF/TA 2.26 > 1.0 |
| NWC/Revenue: -0.50% < 20% (prev -1.01%; Δ 0.51% < -1%) |
| CFO/TA 0.30 > 3% & CFO 1.62b > Net Income 1.39b |
| Net Debt (3.49b) to EBITDA (2.53b): 1.38 < 3 |
| Current Ratio: 0.98 > 1.5 & < 3 |
| Outstanding Shares: last quarter (153.8m) vs 12m ago -7.35% < -2% |
| Gross Margin: 45.69% > 18% (prev 0.48%; Δ 4521 % > 0.5%) |
| Asset Turnover: 199.5% > 50% (prev 125.5%; Δ 74.07% > 0%) |
| Interest Coverage Ratio: 10.50 > 6 (EBITDA TTM 2.53b / Interest Expense TTM 223.8m) |
Altman Z'' 2.51
| A: -0.01 (Total Current Assets 2.05b - Total Current Liabilities 2.10b) / Total Assets 5.34b |
| B: -0.06 (Retained Earnings -302.0m / Total Assets 5.34b) |
| C: 0.46 (EBIT TTM 2.35b / Avg Total Assets 5.08b) |
| D: -0.34 (Book Value of Equity -2.74b / Total Liabilities 8.08b) |
| Altman-Z'' Score: 2.51 = A |
Beneish M -2.57
| DSRI: 0.85 (Receivables 880.0m/615.0m, Revenue 10.13b/6.04b) |
| GMI: 1.05 (GM 45.69% / 48.17%) |
| AQI: 1.15 (AQ_t 0.54 / AQ_t-1 0.47) |
| SGI: 1.68 (Revenue 10.13b / 6.04b) |
| TATA: -0.04 (NI 1.39b - CFO 1.62b) / TA 5.34b) |
| Beneish M-Score: -2.57 (Cap -4..+1) = A |
What is the price of IHG shares?
As of March 03, 2026, the stock is trading at USD 133.78 with a total of 501,480 shares traded.
Over the past week, the price has changed by -6.35%, over one month by -5.90%, over three months by -1.04% and over the past year by +8.29%.
Over the past week, the price has changed by -6.35%, over one month by -5.90%, over three months by -1.04% and over the past year by +8.29%.
Is IHG a buy, sell or hold?
InterContinental Hotels has received a consensus analysts rating of 3.75.
Therefor, it is recommend to hold IHG.
- StrongBuy: 1
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the IHG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 137 | 2.4% |
| Analysts Target Price | 137 | 2.4% |
IHG Fundamental Data Overview March 03, 2026
P/E Trailing = 28.5503
P/E Forward = 24.4499
P/S = 4.0226
P/EG = 1.0923
Revenue TTM = 10.13b USD
EBIT TTM = 2.35b USD
EBITDA TTM = 2.53b USD
Long Term Debt = 3.72b USD (from longTermDebt, last quarter)
Short Term Debt = 506.0m USD (from shortTermDebt, last quarter)
Debt = 4.62b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.49b USD (from netDebt column, last quarter)
Enterprise Value = 24.36b USD (20.87b + Debt 4.62b - CCE 1.13b)
Interest Coverage Ratio = 10.50 (Ebit TTM 2.35b / Interest Expense TTM 223.8m)
EV/FCF = 15.60x (Enterprise Value 24.36b / FCF TTM 1.56b)
FCF Yield = 6.41% (FCF TTM 1.56b / Enterprise Value 24.36b)
FCF Margin = 15.41% (FCF TTM 1.56b / Revenue TTM 10.13b)
Net Margin = 13.72% (Net Income TTM 1.39b / Revenue TTM 10.13b)
Gross Margin = 45.69% ((Revenue TTM 10.13b - Cost of Revenue TTM 5.50b) / Revenue TTM)
Gross Margin QoQ = 36.67% (prev 25.49%)
Tobins Q-Ratio = 4.56 (Enterprise Value 24.36b / Total Assets 5.34b)
Interest Expense / Debt = 0.06% (Interest Expense 3.00m / Debt 4.62b)
Taxrate = 34.24% (151.0m / 441.0m)
NOPAT = 1.55b (EBIT 2.35b * (1 - 34.24%))
Current Ratio = 0.98 (Total Current Assets 2.05b / Total Current Liabilities 2.10b)
Debt / Equity = -1.69 (negative equity) (Debt 4.62b / totalStockholderEquity, last quarter -2.74b)
Debt / EBITDA = 1.38 (Net Debt 3.49b / EBITDA 2.53b)
Debt / FCF = 2.23 (Net Debt 3.49b / FCF TTM 1.56b)
Total Stockholder Equity = -2.48b (last 4 quarters mean from totalStockholderEquity)
RoA = 27.37% (Net Income 1.39b / Total Assets 5.34b)
RoE = -56.16% (negative equity) (Net Income TTM 1.39b / Total Stockholder Equity -2.48b)
RoCE = 188.4% (EBIT 2.35b / Capital Employed (Equity -2.48b + L.T.Debt 3.72b))
RoIC = 157.1% (NOPAT 1.55b / Invested Capital 984.0m)
WACC = 7.48% (E(20.87b)/V(25.49b) * Re(9.12%) + D(4.62b)/V(25.49b) * Rd(0.06%) * (1-Tc(0.34)))
Discount Rate = 9.12% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.74%
[DCF] Terminal Value 82.99% ; FCFF base≈1.46b ; Y1≈1.80b ; Y5≈3.06b
[DCF] Fair Price = 361.8 (EV 57.81b - Net Debt 3.49b = Equity 54.32b / Shares 150.1m; r=7.48% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 53.71 | EPS CAGR: 131.4% | SUE: 0.0 | # QB: 0
Revenue Correlation: 82.44 | Revenue CAGR: 58.78% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=6.00 | Chg7d=+0.206 | Chg30d=+0.202 | Revisions Net=-1 | Growth EPS=+0.0% | Growth Revenue=+6.9%
EPS next Year (2027-12-31): EPS=6.61 | Chg7d=-0.070 | Chg30d=-0.070 | Revisions Net=+0 | Growth EPS=+10.3% | Growth Revenue=+5.7%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 5.6% (Discount Rate 9.1% - Earnings Yield 3.5%)
[Growth] Growth Spread = +0.0% (Analyst 5.7% - Implied 5.6%)
P/E Forward = 24.4499
P/S = 4.0226
P/EG = 1.0923
Revenue TTM = 10.13b USD
EBIT TTM = 2.35b USD
EBITDA TTM = 2.53b USD
Long Term Debt = 3.72b USD (from longTermDebt, last quarter)
Short Term Debt = 506.0m USD (from shortTermDebt, last quarter)
Debt = 4.62b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.49b USD (from netDebt column, last quarter)
Enterprise Value = 24.36b USD (20.87b + Debt 4.62b - CCE 1.13b)
Interest Coverage Ratio = 10.50 (Ebit TTM 2.35b / Interest Expense TTM 223.8m)
EV/FCF = 15.60x (Enterprise Value 24.36b / FCF TTM 1.56b)
FCF Yield = 6.41% (FCF TTM 1.56b / Enterprise Value 24.36b)
FCF Margin = 15.41% (FCF TTM 1.56b / Revenue TTM 10.13b)
Net Margin = 13.72% (Net Income TTM 1.39b / Revenue TTM 10.13b)
Gross Margin = 45.69% ((Revenue TTM 10.13b - Cost of Revenue TTM 5.50b) / Revenue TTM)
Gross Margin QoQ = 36.67% (prev 25.49%)
Tobins Q-Ratio = 4.56 (Enterprise Value 24.36b / Total Assets 5.34b)
Interest Expense / Debt = 0.06% (Interest Expense 3.00m / Debt 4.62b)
Taxrate = 34.24% (151.0m / 441.0m)
NOPAT = 1.55b (EBIT 2.35b * (1 - 34.24%))
Current Ratio = 0.98 (Total Current Assets 2.05b / Total Current Liabilities 2.10b)
Debt / Equity = -1.69 (negative equity) (Debt 4.62b / totalStockholderEquity, last quarter -2.74b)
Debt / EBITDA = 1.38 (Net Debt 3.49b / EBITDA 2.53b)
Debt / FCF = 2.23 (Net Debt 3.49b / FCF TTM 1.56b)
Total Stockholder Equity = -2.48b (last 4 quarters mean from totalStockholderEquity)
RoA = 27.37% (Net Income 1.39b / Total Assets 5.34b)
RoE = -56.16% (negative equity) (Net Income TTM 1.39b / Total Stockholder Equity -2.48b)
RoCE = 188.4% (EBIT 2.35b / Capital Employed (Equity -2.48b + L.T.Debt 3.72b))
RoIC = 157.1% (NOPAT 1.55b / Invested Capital 984.0m)
WACC = 7.48% (E(20.87b)/V(25.49b) * Re(9.12%) + D(4.62b)/V(25.49b) * Rd(0.06%) * (1-Tc(0.34)))
Discount Rate = 9.12% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.74%
[DCF] Terminal Value 82.99% ; FCFF base≈1.46b ; Y1≈1.80b ; Y5≈3.06b
[DCF] Fair Price = 361.8 (EV 57.81b - Net Debt 3.49b = Equity 54.32b / Shares 150.1m; r=7.48% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 53.71 | EPS CAGR: 131.4% | SUE: 0.0 | # QB: 0
Revenue Correlation: 82.44 | Revenue CAGR: 58.78% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=6.00 | Chg7d=+0.206 | Chg30d=+0.202 | Revisions Net=-1 | Growth EPS=+0.0% | Growth Revenue=+6.9%
EPS next Year (2027-12-31): EPS=6.61 | Chg7d=-0.070 | Chg30d=-0.070 | Revisions Net=+0 | Growth EPS=+10.3% | Growth Revenue=+5.7%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 5.6% (Discount Rate 9.1% - Earnings Yield 3.5%)
[Growth] Growth Spread = +0.0% (Analyst 5.7% - Implied 5.6%)